ANP.LSE Anpario Plc
- Market cap
- GBX 85.6M
- P/E
- 13.5x
- P/B
- 1.99x
- ROE
- 29.2%
- Dividend yield
- 2.43%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is ANP.LSE undervalued?
Graham numberANP.LSE trades 9.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Anpario Plc fundamental analysis
No fundamental analysis for Anpario Plc yet.
Anpario Plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Anpario Plc
Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and omega fatty acids under the AmpLIPhy, Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and…
Full company profileAnpario Plc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Anpario Plc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 24.3M | 29.2M | 28.3M | 29.0M | 30.5M | 33.4M | 33.1M | 31.0M | 38.2M | 47.2M | 97.2M |
| Gross Profit | 11.4M | 14.3M | 13.5M | 13.9M | 15.2M | 15.5M | 13.5M | 14.0M | 17.3M | 23.4M | 47.7M |
| Operating Income | 3.64M | 3.99M | 4.47M | 4.65M | 5.27M | 5.65M | 3.61M | 2.52M | 4.89M | 7.89M | 14.8M |
| EBITDA | 3.24M | 4.81M | 5.55M | 5.54M | 6.59M | 6.98M | 4.91M | 4.00M | 6.38M | 9.33M | 17.6M |
| Net Income | 2.58M | 2.99M | 4.00M | 3.72M | 4.21M | 4.68M | 3.30M | 2.53M | 4.11M | 6.75M | 12.3M |
| EPS | 0.13 | 0.14 | 0.19 | 0.18 | 0.20 | 0.21 | 0.15 | 0.13 | 0.24 | 0.38 | 0.68 |
| Balance Sheet | |||||||||||
| Total Assets | 34.0M | 37.2M | 38.2M | 40.4M | 44.5M | 48.0M | 48.5M | 40.2M | 47.1M | 50.5M | 49.5M |
| Total Liabilities | 5.51M | 6.68M | 5.05M | 4.87M | 6.97M | 7.68M | 7.22M | 6.55M | 10.9M | 9.53M | 7.36M |
| Shareholders' Equity | 28.5M | 30.5M | 33.1M | 35.6M | 37.5M | 40.3M | 41.3M | 33.6M | 36.3M | 41.0M | 42.1M |
| Cash & Short-term Investments | 11.1M | 13.6M | 12.9M | 13.8M | 15.8M | 15.5M | 13.6M | 10.6M | 10.5M | 12.4M | 11.0M |
| Total Debt | - | - | 198K | 188K | 90.0K | 85.0K | 52.0K | 79.0K | 74.0K | 244K | 252K |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.80M | 5.23M | 2.69M | 3.97M | 5.83M | 3.15M | 1.09M | 8.70M | 5.84M | 6.02M | 4.14M |
| Capital Expenditure | 729K | 151K | 695K | 1.67M | 1.26M | 1.42M | 1.54M | 743K | 1.94M | 566K | 1.15M |
| Free Cash Flow | 3.07M | 5.08M | 1.99M | 2.30M | 4.57M | 1.72M | -453K | 7.95M | 4.20M | 5.46M | 2.99M |
| Ratios | |||||||||||
| ROE | 9.0% | 9.8% | 12.1% | 10.4% | 11.2% | 11.6% | 8.0% | 7.5% | 11.3% | 16.5% | 29.2% |
| ROA | 7.6% | 8.0% | 10.5% | 9.2% | 9.5% | 9.8% | 6.8% | 6.3% | 8.7% | 13.4% | 24.9% |
| Net Profit Margin | 10.6% | 10.2% | 14.1% | 12.8% | 13.8% | 14.0% | 10.0% | 8.2% | 10.8% | 14.3% | 12.7% |
| Debt to Equity | - | - | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Anpario Plc dividends
- Dividend yield
- 2.43%
- Forward dividend
- 0.13 GBX
- Payout ratio
- 30.5%
- Ex-dividend date
- Nov 12, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | GBP 2.06M | 0.12 | 30.5% |
| 2024 | GBP 1.83M | 0.11 | 44.5% |
| 2023 | GBP 1.76M | 0.09 | 69.7% |
| 2022 | GBP 2.19M | 0.10 | 66.2% |
| 2021 | GBP 2.02M | 0.09 | 43.2% |
| 2020 | GBP 1.73M | 0.08 | 41.1% |
| 2019 | GBP 1.57M | 0.07 | 42.2% |
| 2018 | GBP 1.43M | 0.07 | 35.8% |
| 2017 | GBP 1.58M | 0.07 | 52.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:23 on Oct 4, 2010.
Who owns Anpario Plc
- Insiders 25.67%
- Institutions 41.29%
- Public & others 33.05%
- Shares outstanding 16.2M
- Free float 14.3M
Anpario Plc company profile
- Company name
- Anpario Plc
- Ticker
- ANP.LSE
- ISIN
- GB00B3NWT178
- Exchange
- London Exchange
- Listed since
- Jun 30, 2005
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 162
- Fiscal year end
- December
- Address
- Manton Wood Enterprise Park, Worksop, United Kingdom, S80 2RS
- Phone
- 44 19 0953 7380
- Website
- anpario.com
About Anpario Plc
Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and omega fatty acids under the AmpLIPhy, Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands. It also provides water sanitation tablets, an insect control powders and natural drying agents under the Red Lite, Credence, Mitex, and Clean & Dry brands; and toxin management category products consisting of mycotoxin binders under the Anpro brand. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.
Anpario Plc management
5- Mr. Richard Peter Edwards B Eng (Hons), B.E., C Eng, M.B.A.Executive Vice Chairman & CEO · born 1965
- Mr. Marc Charles Wilson A.C.M.A., B.A.Group Finance Director & Director · born 1988
- Ms. Karen Lesley Prior B.Sc., B.Sc. (Hons), F.C.A.Corporate Responsibility Director, Company Secretary & Director · born 1960
- Mr. Shane BaileyOperations Director
- Ms. Sarah Osborne BSc. HonsCorporate Development Director